billHR9863Event Wednesday, July 22, 2026Analyzed

To direct the Director of the Defense Health Agency to submit to Congress a report on the feasibility of establishing a pilot program that establishes a behavioral neurology fellowship program to provide training opportunities with respect to treating members of the Armed Forces and veterans with traumatic brain injuries.

Neutral

Summary

HR9863 is an early-stage bill directing a feasibility report on a behavioral neurology fellowship for TBI treatment. It authorizes no funding and has no direct market impact. No tickers are affected at this stage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR9863 is a procedural bill requiring a report, not a spending program.
  • 2.No direct revenue impact on any public company; no tickers to trade.
  • 3.Investors should monitor only if the bill progresses to a funded pilot program, which is unlikely in the near term.

Market Implications

No market implications. The bill does not affect revenue, costs, or competitive positioning for any publicly traded company. Investors should ignore this legislation until it advances to a funded program stage.

Full Analysis

HR9863, introduced July 22, 2026, by Rep. Neguse (D-CO) and cosponsored by Rep. Luttrell (R-TX), requires the Director of the Defense Health Agency to submit a report to Congress within 270 days on the feasibility of establishing a pilot behavioral neurology fellowship program for treating traumatic brain injuries in service members and veterans. The bill is currently in the House Committee on Armed Services. It is purely a study mandate—no funding is authorized or appropriated. The legislative path requires committee markup, House passage, Senate companion, and presidential signature. Even if enacted, the report would not create a program or allocate money; actual implementation would require subsequent authorization and appropriations. No public companies are directly impacted by a feasibility study. The presidential action on chemical manufacturing regulatory relief is unrelated and ignored. There is no convergence with other signals in the provided data. The bill's impact on markets is negligible at this stage.

Key Legislators

Rep. Neguse, Joe [D-CO-2]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Exec OrderAug 6, 2026

Ending Birth Tourism

This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →